DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - Q4 2015 holdings

$2.47 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 109 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 55.7% .

 Value Shares↓ Weighting
NXTM SellNXSTAGE MEDICAL INC$100,545,000
+0.9%
4,589,000
-27.4%
4.08%
+5.7%
DYAX SellDYAX CORP$84,347,000
+54.6%
2,242,073
-21.5%
3.42%
+62.0%
GSK SellGLAXOSMITHKLINE PLCsponsored adr$67,602,000
-23.0%
1,675,385
-26.6%
2.74%
-19.3%
AET SellAETNA INC NEW$63,949,000
-8.1%
591,465
-7.0%
2.59%
-3.7%
MYL SellMYLAN N V$57,098,000
+11.2%
1,056,000
-17.2%
2.31%
+16.5%
ARRY SellARRAY BIOPHARMA INC$36,838,000
-17.0%
8,729,361
-10.3%
1.49%
-13.0%
SAGE SellSAGE THERAPEUTICS INC$34,913,000
+27.1%
598,854
-7.7%
1.42%
+33.1%
UAM SellUNIVERSAL AMERN CORP NEW$33,523,000
-0.6%
4,789,027
-2.9%
1.36%
+4.1%
WBA SellWALGREENS BOOTS ALLIANCE INC$32,909,000
-14.6%
386,457
-16.6%
1.33%
-10.5%
CRL SellCHARLES RIV LABS INTL INC$30,322,000
-17.9%
377,188
-35.1%
1.23%
-13.9%
MCK SellMCKESSON CORP$28,529,000
-16.9%
144,646
-22.1%
1.16%
-13.0%
PCRX SellPACIRA PHARMACEUTICALS INC$28,489,000
-1.3%
371,000
-47.2%
1.16%
+3.4%
GHDX SellGENOMIC HEALTH INC$28,492,000
+23.1%
809,432
-26.0%
1.16%
+29.1%
RLYP SellRELYPSA INC$25,514,000
+25.2%
900,281
-18.2%
1.03%
+31.2%
SellSPECTRANETICS CORPmtnf 2.625% 6/0$22,537,000
-25.5%
29,831,000
-25.1%
0.91%
-22.0%
GWPH SellGW PHARMACEUTICALS PLCads$21,535,000
-39.7%
310,122
-20.7%
0.87%
-36.8%
RAD SellRITE AID CORP$19,543,000
-23.8%
2,492,772
-41.0%
0.79%
-20.2%
RGNX SellREGENXBIO INC$19,406,000
-34.1%
1,169,042
-12.5%
0.79%
-30.9%
XNCR SellXENCOR INC$18,372,000
-15.9%
1,256,612
-29.7%
0.74%
-11.8%
PACB SellPACIFIC BIOSCIENCES CALIF IN$18,224,000
+127.8%
1,388,000
-36.5%
0.74%
+139.2%
SellFLUIDIGM CORP DELnote 2.750% 2/0$17,603,000
-30.2%
27,715,000
-20.8%
0.71%
-26.9%
MGNX SellMACROGENICS INC$16,040,000
+34.4%
517,920
-7.0%
0.65%
+40.7%
SellALLSCRIPTS HEALTHCARE SOLUTNnote 1.250% 7/0$13,412,000
-86.6%
12,400,000
-87.7%
0.54%
-85.9%
GLPG SellGALAPAGOS NVspon adr$11,507,000
-35.9%
183,000
-58.5%
0.47%
-32.9%
TRUP SellTRUPANION INC$10,367,000
-13.0%
1,062,214
-32.7%
0.42%
-8.9%
LOXO SellLOXO ONCOLOGY INC$7,141,000
-62.5%
251,000
-76.9%
0.29%
-60.7%
ATRS SellANTARES PHARMA INC$4,820,000
-81.6%
3,983,440
-74.2%
0.20%
-80.8%
GENN SellGENESIS HEALTHCARE INC$3,344,000
-64.5%
963,564
-37.4%
0.14%
-62.7%
CDTX SellCIDARA THERAPEUTICS INC$2,050,000
-32.2%
119,456
-49.7%
0.08%
-29.1%
ANTM SellANTHEM INC$2,043,000
-89.6%
14,649
-89.6%
0.08%
-89.1%
STRM SellSTREAMLINE HEALTH SOLUTIONS$935,000
-82.0%
662,971
-70.8%
0.04%
-81.1%
TRXC ExitTRANSENTERIX INC$0-61,819
-100.0%
-0.01%
VRX ExitVALEANT PHARMACEUTICALS INTL$0-1,575
-100.0%
-0.01%
OPHT ExitOPHTHOTECH CORP$0-10,000
-100.0%
-0.02%
SEM ExitSELECT MED HLDGS CORP$0-55,000
-100.0%
-0.02%
CAH ExitCARDINAL HEALTH INC$0-8,000
-100.0%
-0.02%
HALO ExitHALOZYME THERAPEUTICS INC$0-50,349
-100.0%
-0.03%
ESPR ExitESPERION THERAPEUTICS INC NE$0-32,970
-100.0%
-0.03%
THC ExitTENET HEALTHCARE CORP$0-27,602
-100.0%
-0.04%
KND ExitKINDRED HEALTHCARE INC$0-72,100
-100.0%
-0.04%
NVTA ExitINVITAE CORP$0-166,666
-100.0%
-0.05%
KIN ExitKINDRED BIOSCIENCES INC$0-279,204
-100.0%
-0.06%
BIIB ExitBIOGEN INC$0-5,500
-100.0%
-0.06%
LJPC ExitLA JOLLA PHARMACEUTICAL CO$0-65,000
-100.0%
-0.07%
ILMN ExitILLUMINA INC$0-11,000
-100.0%
-0.08%
VRTX ExitVERTEX PHARMACEUTICALS INC$0-18,500
-100.0%
-0.08%
MZOR ExitMAZOR ROBOTICS LTDsponsored ads$0-228,909
-100.0%
-0.10%
DSCO ExitDISCOVERY LABORATORIES INC N$0-8,537,995
-100.0%
-0.10%
BEAT ExitBIOTELEMETRY INC$0-222,215
-100.0%
-0.10%
BITI ExitBIOTIE THERAPIES OYJsponsored adr$0-219,558
-100.0%
-0.11%
PRQR ExitPROQR THRAPEUTICS N V$0-209,398
-100.0%
-0.12%
MRTX ExitMIRATI THERAPEUTICS INC$0-110,049
-100.0%
-0.15%
BDSI ExitBIODELIVERY SCIENCES INTL IN$0-700,000
-100.0%
-0.15%
PEN ExitPENUMBRA INC$0-100,000
-100.0%
-0.16%
AKRXQ ExitAKORN INC$0-160,667
-100.0%
-0.18%
LIFE ExitATYR PHARMA INC$0-461,530
-100.0%
-0.18%
DSCI ExitDERMA SCIENCES INC$0-1,002,201
-100.0%
-0.18%
AXGT ExitAXOVANT SCIENCES LTD$0-484,664
-100.0%
-0.24%
NVAX ExitNOVAVAX INC$0-1,040,000
-100.0%
-0.28%
ARNA ExitARENA PHARMACEUTICALS INC$0-4,640,877
-100.0%
-0.34%
OFIX ExitORTHOFIX INTL N V$0-360,459
-100.0%
-0.47%
BKD ExitBROOKDALE SR LIVING INC$0-557,000
-100.0%
-0.50%
NUVA ExitNUVASIVE INC$0-265,272
-100.0%
-0.50%
ZLTQ ExitZELTIQ AESTHETICS INC$0-420,063
-100.0%
-0.52%
EW ExitEDWARDS LIFESCIENCES CORP$0-97,119
-100.0%
-0.53%
ELOS ExitSYNERON MEDICAL LTD$0-2,079,013
-100.0%
-0.58%
MNKKQ ExitMALLINCKRODT PUB LTD CO$0-317,931
-100.0%
-0.79%
ExitWEBMD HEALTH CORPnote 1.500%12/0$0-23,000,000
-100.0%
-0.91%
ELGX ExitENDOLOGIX INC$0-2,347,113
-100.0%
-1.11%
BLUE ExitBLUEBIRD BIO INC$0-483,000
-100.0%
-1.60%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-02-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AERIE PHARMACEUTICALS INC36Q3 20223.6%
CENTENE CORP DEL30Q3 20233.0%
BIOCRYST PHARMACEUTICALS INC29Q3 20232.2%
MOLINA HEALTHCARE INC26Q3 20221.7%
EHEALTH INC25Q3 20202.0%
INTERCEPT PHARMACEUTICALS IN24Q1 20232.2%
MYLAN NV23Q3 20206.2%
PORTOLA PHARMACEUTICALS INC23Q1 20196.0%
BROOKDALE SR LIVING INC23Q3 20232.2%
ALIMERA SCIENCES INC23Q3 20190.8%

View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.

Latest significant ownerships (13-D/G)
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) Q4 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
DA32 Life Science Tech Acquisition Corp.August 01, 20235,145,00091.1%
CareMax, Inc.March 13, 202318,691,42316.4%
CareMax, Inc.June 02, 202218,691,42320.7%

View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.

Latest filings
TypeFiled
42024-06-14
42024-06-03
13F-HR2024-05-15
32024-03-19
42024-03-19
42024-03-12
32024-03-08
42024-02-16
13F-HR2024-02-14
42024-02-08

View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (2467380000.0 != 2467381000.0)

Export DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s holdings